These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15971341)

  • 1. CNAO--The Italian Centre for Light-Ion Therapy.
    Amaldi U
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S191-201. PubMed ID: 15971341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Italian hadrontherapy project CNAO.
    Amaldi U
    Phys Med; 2001; 17 Suppl 1():33-7. PubMed ID: 11770534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical aspects of the National Centre For Oncological Hadrontherapy (CNAO-Centro Nazionale Adroterapia Oncologica) in Italy.
    Krengli M; Orecchia R
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S21-3. PubMed ID: 15971303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformal radiation therapy with hadron beams and the programs of the TERA Foundation.
    Amaldi U
    Rays; 1998; 23(3):486-507. PubMed ID: 9932467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam radiotherapy: report of the first ten patients treated at the "Centro Nazionale di Adroterapia Oncologica (CNAO)" for skull base and spine tumours.
    Orecchia R; Vitolo V; Fiore MR; Fossati P; Iannalfi A; Vischioni B; Srivastava A; Tuan J; Ciocca M; Molinelli S; Mirandola A; Vilches G; Mairani A; Tagaste B; Riboldi M; Fontana G; Baroni G; Rossi S; Krengli M
    Radiol Med; 2014 Apr; 119(4):277-82. PubMed ID: 24337759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress of the Proton-Ion Medical Machine Study (PIMMS).
    Bryant PJ
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():1-4. PubMed ID: 10394382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hadrontherapy in the world and the programmes of the TERA Foundation.
    Amaldi U
    Tumori; 1998; 84(2):188-99. PubMed ID: 9620244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Italian National Center for Oncological Adrotherapy (CNAO): status and perspectives].
    Rossi S
    G Ital Med Lav Ergon; 2020 Dec; 42(4):247-251. PubMed ID: 33600648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A platform for patient positioning and motion monitoring in ocular proton therapy with a non-dedicated beamline.
    Via R; Pella A; Romanò F; Fassi A; Ricotti R; Tagaste B; Vai A; Mastella E; Rosaria Fiore M; Valvo F; Ciocca M; Baroni G
    Phys Med; 2019 Mar; 59():55-63. PubMed ID: 30928066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of MedAustron.
    Griesmayer E; Auberger T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S202-5. PubMed ID: 15971342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SU-E-T-298: Evaluation of the CNAO Spot Scanning Technique Based on the First Clinical Deliveries.
    Hosseini MA; Donetti M; Garella MA; Giordanengo S; Lavagno M; Capasso L; Cirio R; Marchetto F; Peroni C; Sacchi R
    Med Phys; 2012 Jun; 39(6Part14):3772. PubMed ID: 28517252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CNAO dose delivery system for modulated scanning ion beam radiotherapy.
    Giordanengo S; Garella MA; Marchetto F; Bourhaleb F; Ciocca M; Mirandola A; Monaco V; Hosseini MA; Peroni C; Sacchi R; Cirio R; Donetti M
    Med Phys; 2015 Jan; 42(1):263-75. PubMed ID: 25563266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton beam radiotherapy: report of the first patient treated at the Centro Nazionale di Adroterapia Oncologica (CNAO) [National Center of Oncologic Hadron Therapy].
    Orecchia R; Srivastava A; Fiore MR; Vitolo V; Fossati P; Vischioni B; Iannalfi A; Tuan J; Ciocca M; Molinelli S; Mirandola A; Vilches G; Mairani A; Tagaste B; Baroni G; Rossi S; Krengli M
    Tumori; 2013; 99(2):e34-7. PubMed ID: 23748826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health surveillance of workers exposed in a hadrontherapy center].
    Delogu A; Taino G; Imbriani M
    G Ital Med Lav Ergon; 2020 Dec; 42(4):262-264. PubMed ID: 33600651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM).
    Giandini T; Tenconi C; Carrara M; Ciocca M; Russo S; Panaino CMV; Cattani F; Ciardo D; Morlino S; Avuzzi B; Bedini N; Villa S; Marvaso G; Romanelli P; Hasegawa A; Vischioni B; Valvo F; Jereczek-Fossa BA; Orecchia R; Valdagni R; Pignoli E
    Tumori; 2017 Sep; 103(5):430-437. PubMed ID: 28708234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future trends in cancer therapy with particle accelerators.
    Amaldi U
    Z Med Phys; 2004; 14(1):7-16. PubMed ID: 15104005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Centre for Oncological Hadrontherapy (CNAO): Status and perspectives.
    Rossi S
    Phys Med; 2015 Jun; 31(4):333-51. PubMed ID: 25840619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beam dumps design and local radiation protection at TERA synchrotron.
    Porta A; Campi F; Agosteo S
    Radiat Prot Dosimetry; 2005; 115(1-4):222-6. PubMed ID: 16381716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of a general-purpose, actively scanned proton beamline for ocular treatments: Geant4 simulations.
    Piersimoni P; Rimoldi A; Riccardi C; Pirola M; Molinelli S; Ciocca M
    J Appl Clin Med Phys; 2015 Mar; 16(2):5227. PubMed ID: 26103195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation protection at Hadron therapy facilities.
    Pelliccioni M
    Radiat Prot Dosimetry; 2011 Jul; 146(4):407-13. PubMed ID: 21733860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.